CCL-11 or Eotaxin-1: An Immune Marker for Ageing and Accelerated Ageing in Neuro-Psychiatric Disorders.

Mariya IvanovskaZakee AbdiMarianna MurdjevaDanielle Silveira MacêdoAnnabel MaesMichael Maes

Published in: Pharmaceuticals (Basel, Switzerland) (2020)

Increased CCL-11 production during inflammatory conditions may play a role in human disease including age-related cognitive decline, schizophrenia, mood disorders and neurodegenerative disorders. Increased CCL-11 production is a new drug target in the treatment and prevention of those disorders.

Keyphrases

cognitive decline
liver injury
bipolar disorder
liver fibrosis
mild cognitive impairment
drug induced
endothelial cells
emergency department
physical activity
combination therapy
replacement therapy